TVTX logo

Travere Therapeutics (TVTX) EV/EBITDA

EV/EBITDA:

-9.81+0.19(+1.90%)
June 27, 2025

Summary

  • As of today (June 28, 2025), TVTX EV/EBITDA is -9.81, with a rise of +0.19 (+1.90%) during the most recent trading session on June 27, 2025.
  • Over the past year, TVTX EV/EBITDA has dropped by -7.07 (-258.03%).
  • TVTX EV/EBITDA is now -105.41% below its all-time high of 181.49.

Performance

TVTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherTVTXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

TVTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+1.9%-1.9%-2.4%
1 m1 month+3.0%-3.0%-3.7%
3 m3 months-21.3%-23.3%-27.5%
6 m6 months-41.1%-10.7%-14.5%
ytdytd-39.7%-11.6%-15.2%
1 y1 year-258.0%+66.3%+78.4%
5 y5 years+27.1%+45.9%-24.5%

TVTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-9.45-3.8%-10.21+3.9%
3 m3-month-7.86-24.8%-13.38+26.7%
6 m6-month-6.95-41.1%-13.38+26.7%
1 y1-year-2.74-258.0%-13.38+26.7%
3 y3-year-2.05-378.5%-13.38+26.7%
5 y5-year-2.05-378.5%-26.18+62.5%
alltimeall time181.49-105.4%-5339+99.8%

TVTX EV/EBITDA History

DateValue
2025
-9.81(+39.7%)
2024
-7.02(+123.6%)
2023
-3.14(-60.4%)
2022
-7.93(-48.2%)
2021
-15.32(+40.4%)
2020
-10.91(+55.0%)
2019
-7.04(-50.8%)
DateValue
2018
-14.31(-29.9%)
2017
-20.40(+3.9%)
2016
-19.64(-450.7%)
2015
5.60(-130.3%)
2014
-18.48(+141.3%)
2013
-7.66(-99.7%)
2012
-2308.72

FAQ

  • What is Travere Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Travere Therapeutics?
  • What is TVTX EV/EBITDA year-to-date change?
  • What is Travere Therapeutics EV/EBITDA year-on-year change?

What is Travere Therapeutics EV/EBITDA?

The current EV/EBITDA of TVTX is -9.81

What is the all time high EV/EBITDA for Travere Therapeutics?

Travere Therapeutics all-time high EV/EBITDA is 181.49

What is TVTX EV/EBITDA year-to-date change?

Travere Therapeutics EV/EBITDA has changed by -2.79 (-39.74%) since the beginning of the year

What is Travere Therapeutics EV/EBITDA year-on-year change?

Over the past year, TVTX EV/EBITDA has changed by -7.07 (-258.03%)
On this page